Skip to main navigation Skip to search Skip to main content

Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection

  • R. Wallich*
  • , N. Bulbuc
  • , G. J. Hämmerling
  • , S. Katzav
  • , S. Segal
  • , M. Feldman
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

385 Scopus citations

Abstract

H-2 gene transfection was used to restore expression of H-2K antigens in metastatic and non-metastatic subclones of a murine fibrosarcoma that lack their major histocompatibility complex-encoded H-2K antigens. De novo expression of H-2K reduced tumorigenicity and abolished the formation of metastasis in syngeneic mice. Expression of H-2K may lead to effective recognition of the disseminating tumour cells by the host immune system.

Original languageEnglish
Pages (from-to)301-305
Number of pages5
JournalNature
Volume315
Issue number6017
DOIs
StatePublished - 1985
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection'. Together they form a unique fingerprint.

Cite this